Background illustration for clinical trials search

Paid Clinical Trials Princeton

Discover 1,670 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

for
Metastatic Nasopharyngeal Carcinoma,
Location: New Brunswick NJ, Basking Ridge NJ, Middletown NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06029270

Phase 2, Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: New Brunswick NJ, Somerville NJ, Basking Ridge NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05987241

Phase 2, Phase 3, Recruiting

A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

for
Nonmuscle-invasive Bladder Cancer
Location: New Brunswick NJ, Pittsburgh PA, Middleburg Heights OH,
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT06971614

Phase 2, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: New Brunswick NJ, New York NY, Hackensack NJ,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase 2, Recruiting

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: New Brunswick NJ, Livingston NJ, Toms River NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04628767

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase 3, Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

for
Locoregional Recurrence,
Location: New Brunswick NJ, New York NY, Hershey PA,
Sponsor: Oana Danciu

Sex: All

Age: 18+

Code: NCT05467891

Phase 2, Recruiting

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: New Brunswick NJ, New Haven CT, Baltimore MD,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06385080

Phase 1, Phase 2, Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for
Advanced Lung Non-Squamous Non-Small Cell Carcinoma,
Location: New Brunswick NJ, Somerville NJ, Basking Ridge NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase 3, Recruiting

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: New Brunswick NJ, Basking Ridge NJ, Middletown NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06484062

Phase 1, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: New Brunswick NJ, Willow Grove PA, Lakewood NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase 2, Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for
Acute Leukemia of Ambiguous Lineage,
Location: New Brunswick NJ, Morristown NJ, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase 2, Recruiting

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Location: New Brunswick NJ, Boston MA, Chicago IL, Austin TX
Sponsor: Cellectis S.A.

Sex: All

Age: 18 - 70+

Code: NCT05607420

Phase 1, Phase 2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: New Brunswick NJ, Somerville NJ, Basking Ridge NJ,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase 3, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Brunswick NJ, Philadelphia PA, Bala-Cynwyd PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase 3, Recruiting

The THOR IDE Study

for
Peripheral Artery Disease, Peripheral Artery Stenosis,
Location: New Brunswick NJ, Browns Mills NJ, Philadelphia PA,
Sponsor: Philips Clinical & Medical Affairs Global

Sex: All

Age: 18+

Code: NCT05916950

Recruiting

Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors

for
Smoking Cessation
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT07210567

Recruiting

Instrument for Glaucoma Early Detection and Monitoring

for
Glaucoma
Location: Raritan NJ, New Haven CT, Birmingham AL, Memphis TN
Sponsor: Synabridge Corporation

Sex: All

Age: 40 - 70+

Code: NCT00578110

Recruiting

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

for
Urothelial Carcinoma, Urothelial Carcinoma Recurrent,
Location: New Brunswick NJ, New York NY, Lake Success NY,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT05874921

Recruiting

Reducing Urban Cervical Cancer Disparities

for
Cervical Cancer, Papilloma Viral Infection
Location: New Brunswick NJ, Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: Female

Age: 18 - 70+

Code: NCT06416150

Recruiting